Zota Health Care confirms no new share encumbrances in FY26
Zota Health Care Limited filed a disclosure with the National Stock Exchange confirming no new encumbrances on shares by promoters or PACs in FY26. The submission, signed by Company Secretary Ashvin Variya, lists 39 individuals and entities in the promoter group. This compliance follows Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

*this image is generated using AI for illustrative purposes only.
Zota Health Care Limited has confirmed that its promoters and Persons Acting in Concert (PAC) did not create any fresh encumbrances on the company's shares during the financial year ended March 31, 2026. This disclosure, submitted to the National Stock Exchange of India Limited, ensures transparency regarding the shareholding status of key stakeholders for FY26.
The declaration was made by Himanshu Muktilal Zota, Promoter and Whole-time Director of the company, on behalf of the promoter group and PAC. The filing explicitly states that no encumbrance was made directly or indirectly other than those already disclosed previously. This compliance is part of the requirements under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Promoter and PAC Details
The disclosure provided a comprehensive list of individuals and entities falling under the promoter and promoter group categories. The list encompasses 39 names, ranging from individual promoters to Hindu Undivided Families (HUFs) and other associated entities.
Classification of Shareholders
| Sr No. | Name | Category |
|---|---|---|
| 1 | Manukant Chandulal Zota | Promoter |
| 2 | Himanshubhai Muktilal Zota | Promoter |
| 3 | Ketankumar Chandulal Zota | Promoter |
| 4 | Kamlesh Rajnikant Zota | Promoter |
| 5 | Zota Manukant Chandulal HUF | Promoter Group |
| 6 | Ashokkumar Chandulal Zota (HUF) | Promoter Group |
| 7 | Zota Ketankumar Chandulal | Promoter Group |
| 8 | Himanshu Muktilal Zota HUF | Promoter Group |
| 9 | Anilaben Ketankumar Zota | Promoter Group |
| 10 | Rasilaben Manukantbhai Zota | Promoter Group |
| 11 | Ashokkumar Chandulal Zota | Promoter Group |
| 12 | Varshaben Himanshubhai Zota | Promoter Group |
| 13 | Niralkumar Muktilal Zota | Promoter Group |
| 14 | Induben Muktilal Zota | Promoter Group |
| 15 | Manishaben Kamleshkumar Zota | Promoter Group |
| 16 | Viren Manukant Zota | Promoter Group |
| 17 | Viren Manukant Zota (HUF) | Promoter Group |
| 18 | Heli Ritesh Shah | Promoter Group |
| 19 | Praful Ratilal Vora | Promoter Group |
| 20 | Moxesh Ketanbhai Zota | Promoter Group |
| 21 | Bhikhalal Chhotalal Doshi | Promoter Group |
| 22 | Dhara Mehta | Promoter Group |
| 23 | Chandrikaben Subodhchandra Shah | Promoter Group |
| 24 | Kinjal Nikesh Mehta | Promoter Group |
| 25 | Anjnaben Shrenikkumar Gandhi | Promoter Group |
| 26 | Halchandbhai Manilal Mehta | Promoter Group |
| 27 | Manjulaben Pravinbhai Shah | Promoter Group |
| 28 | Kenvi Zota | Promoter Group |
| 29 | Vinodchandra Dhirajlal Mehta | Promoter Group |
| 30 | Sureshkumar Halchandbhai Mehta | Promoter Group |
| 31 | Krinal V Ankhad | Promoter Group |
| 32 | Manisha Tusharkumar Mehta | Promoter Group |
| 33 | Nitaben Rajeshbhai Mehta | Promoter Group |
| 34 | Arunaben Rameshkumar Shah | Promoter Group |
| 35 | Shripal R Mehta | Promoter Group |
| 36 | Kumarpal Rajnikant Mehta | Promoter Group |
| 37 | Nirmalaben A Shah | Promoter Group |
| 38 | Ramila R Mehta | Promoter Group |
| 39 | Dimple Dhaval Shah | Promoter Group |
The filing was signed by Ashvin Variya, Company Secretary & Compliance Officer, on April 04, 2026. The registered office of Zota Health Care Limited is located at Zota House, Sagrampura, Surat.
Historical Stock Returns for Zota Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.55% | +0.90% | +0.59% | -27.98% | +26.58% | +594.43% |
How will the absence of fresh encumbrances impact Zota Health Care's ability to secure future financing for expansion?
What strategic capital allocation plans does the company have for FY27 given the stable promoter shareholding status?
Could this clean encumbrance status make Zota Health Care a more attractive target for potential mergers or acquisitions?


































